Where can I buy shares of Dendreon stock?

Where can I buy shares of Dendreon stock?

Dendreon trades on the OTCMKTS under the ticker symbol “DNDNQ.” How do I buy shares of Dendreon? Shares of DNDNQ can be purchased through any online brokerage account.

How is Dendreon making a difference in cancer treatment?

Delivering breakthrough immunotherapies that are changing the future of cancer treatment. Revolutionizing cancer treatment through our leadership in immunotherapy. Making a difference in the lives of people living with cancer. Stay up to date with the latest discoveries, events, and announcements from Dendreon.

What was the earnings per share for dndnq?

The biotechnology company earned $73.10 million during the quarter, compared to analyst estimates of $78.72 million. The business’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period last year, the business earned ($0.44) EPS.

What kind of rating does dndnq have on marketbeat?

Wall Street analysts have given (DNDNQ) a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but (DNDNQ) wasn’t one of them.

Dendreon trades on the OTCMKTS under the ticker symbol “DNDNQ.” How do I buy shares of Dendreon? Shares of DNDNQ can be purchased through any online brokerage account.

The biotechnology company earned $73.10 million during the quarter, compared to analyst estimates of $78.72 million. The business’s quarterly revenue was up 7.5% on a year-over-year basis. During the same period last year, the business earned ($0.44) EPS.

Delivering breakthrough immunotherapies that are changing the future of cancer treatment. Revolutionizing cancer treatment through our leadership in immunotherapy. Making a difference in the lives of people living with cancer. Stay up to date with the latest discoveries, events, and announcements from Dendreon.

Wall Street analysts have given (DNDNQ) a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but (DNDNQ) wasn’t one of them.